Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 13/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 7/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.57 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.57 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.57 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 0.57 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.50 |
| ▸ | JAK2 | O60674 | 1/20 | 0.50 |
| ▸ | FLT3 | P36888 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | NCOR1 | O75376 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL211385 | 0.86 | MAPT (0.63) | PTGS1HDAC1HDAC3HDAC8HDAC4 | |
| SCHEMBL211403 | 0.79 | ADRB1 (0.56) | ALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL14108040 | 0.78 | PTGS1 (0.67) | PTGS1HDAC1HDAC3HDAC8HDAC4 | |
| SCHEMBL8077840 | 0.76 | HDAC1 (0.80) | PTGS1HDAC1HDAC3HDAC8HDAC4 | |
| SCHEMBL2830015 | 0.75 | HDAC1 (0.74) | HDAC1HDAC3HDAC8HDAC4HDAC7 | |
| SCHEMBL8268732 | 0.74 | PTGS1 (0.56) | PTGS1HDAC1HDAC3HDAC8HDAC4 | |
| SCHEMBL4898506 | 0.74 | PTGS1 (0.57) | PTGS1HDAC1HDAC3HDAC8HDAC4 | |
| SCHEMBL1064411 | 0.74 | HDAC1 (1.00) | HDAC1HDAC3HDAC8HDAC4HDAC7 | |
| SCHEMBL29809952 | 0.73 | TP53 (0.52) | TP53GAAALDH1A1MAPTHPGD | |
| SCHEMBL28845694 | 0.73 | TP53 (0.52) | TP53GAAALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088805-B2 | Inhibitors of histone deacetylase | METHYLGENE INC. (CA) | 2012-01-03 | — | — | US | disclosed |
| US-20070213330-A1 | Anticancer agents; antiproliferative agents | METHYLGENE INC. (CA) | 2007-09-13 | — | — | US | disclosed |
| US-7253204-B2 | Antiproliferative agents | METHYLGENE INC. (CA) | 2007-08-07 | — | — | US | disclosed |
| EP-1735319-A1 | INHIBITORS OF HISTONE DEACETYLASE | Methylgene, Inc. (CA) | 2006-12-27 | — | — | EP | disclosed |
| US-20050245518-A1 | Antiproliferative agents | METHYLGENE, INC. | 2005-11-03 | — | — | US | disclosed |
| WO-2005092899-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2005-10-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213330-A1 | Anticancer agents; antiproliferative agents | HDAC1, HDAC11, HDAC5 | PTGS1 2062/4885HDAC1 1/4885HDAC3 4/4885 |
| US-20050245518-A1 | Antiproliferative agents | HDAC1, HDAC11, HDAC5 | PTGS1 1873/4885HDAC1 1/4885HDAC3 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.